🧠 Neurological conditions affect over 1 in 3 people worldwide, yet care remains out of reach for most.
Today, @WHO launched the Global status report on neurology, calling for urgent attention for improved neurological care and brain health for all.
▶️ tinyurl.com/WHONeuroGSR
The WHO’s Global Status Report on Neurology offers the first global assessment of how countries are responding to neurological disorders under #IGAP (2022–2031). It exposes urgent gaps in care, access & research—calling for stronger global action on #BrainHealth.
🔗 bit.ly/49mBKSY#Neurology#GlobalHealth#WHO
WHO: Neurologische Versorgung erfordert dringenden Handlungsbedarf: Genf/Seoul – Die Weltgesundheitsorganisation (WHO) warnt in ihrem aktuellen Globalen Statusbericht zur Neurologie (Global status report on neurology), dass weniger als eines… dlvr.it/TNhGCz
Neurological conditions now affect over 3 billion people – about 40% of the global population & cause over 11 million deaths each year. Yet fewer than 1 in 3 countries have a national policy in place.
Learn more in @WHO’s Global Status Report on Neurology:
who.int/news/item/14-10-2025…
JUST PUBLISHED: Global status report on neurology
The growing burden of #neurological disorders represents a major global public health issue. Every year, disorders such as stroke, meningitis and #epilepsy kill over eleven million people, making them the world’s leading cause of ill health and disability combined. Over forty percent of the world’s population are living with a neurological disorder, impairing the physical and #mental health, quality of life and well-being, and ability for full participation in society of those affected.
The inequities in neurological care remain substantial. People in low- and middle-income countries are disproportionally affected by neurological disorders, while #health systems in many parts of the world still lack the resources to adequately address the scope of the problem. This burden is complicated by #stigma and discrimination which can hamper lives, increase the risk of poverty, and make accessing care even more difficult. Yet many neurological disorders are preventable or treatable through existing interventions, and research advances increasingly lead to more effective prevention, treatment and care.
The Intersectoral global action plan on epilepsy and other neurological disorders 2022–2031 marks a historic milestone in public health policy. It presents an unprecedented opportunity to confront the growing global burden of neurological conditions and to promote #brain health across the life course. WHO stands fully committed to working alongside Member States, people with lived experience and civil society to implement this transformative plan and achieve its ten ambitious targets by 2031.
Report available here iris.who.int/handle/10665/38…
WHO urges governments to:
✔️ Make brain health a policy priority
✔️ Expand access to care without financial hardship
✔️ Promote brain health across the life course
✔️ Strengthen data systems & monitoring
✔️ Involve people with lived experience
New report bit.ly/4oj81yH
Neurological conditions often require lifelong care.
Yet fewer than half of countries offer carer services or legal protections.
Most carers are women, yet they remain largely unrecognised and unsupported.
Report bit.ly/4oj81yH
🌍 Populations in low- and middle-income countries carry 80% of the global burden of neurological disorders, yet they often have the least resources to care for the people affected.
⚠️ Low-income countries have up to 82x fewer neurologists than high-income countries.
🧠 Over 1 in 3 people live with a neurological condition. Many can be prevented or treated, yet care remains out of reach for most.
Today, @WHO launches the Global status report on neurology, calling for urgent global action on #brainhealth: bit.ly/4oj81yH
1 in 3 people is living with neurological condition, such as stroke, epilepsy, migraine, autism.
Despite the number of people with these conditions, those in low- and middle- income countries face the greatest challenges.
New WHO report bit.ly/4oj81yH
Concurrent treatment with dual immune-checkpoint inhibitors plus radiosurgery was associated with an increased risk of symptomatic radionecrosis in patients with melanoma and non-small cell lung cancer brain metastases.
ja.ma/4jvrYQx